DISTINCT LYSOZYME CONTENT IN DIFFERENT SUBTYPES OF ACUTE MYELOID LEUKEMIC-CELLS - AN ULTRASTRUCTURAL IMMUNOGOLD STUDY

被引:9
作者
RESNITZKY, P [1 ]
SHAFT, D [1 ]
机构
[1] KAPLAN HOSP,DEPT MED B,IL-76100 REHOVOT,ISRAEL
关键词
ANLL; MYELOMONOCYTIC LEUKEMIA; LYSOZYME IMMUNOGOLD; PEROXIDASE; ULTRASTRUCTURE;
D O I
10.1111/j.1365-2141.1994.tb05031.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Using an ultrastructural immunogold method, we performed a quantitative study on cellular lysozyme (LZ) content in young normal bone marrow cells and in 14 cases of acute myeloid leukaemia (AML) of the M2, M3, M4 and M5 types. In five cases of M2 we found significantly lower LZ content than in normal promyelocytes and than in nine cases of M3, M4 and M5. In M3, M4 and M5 cells a very high LZ content was observed whereas the serum LZ activity was high in M4 and M5 and normal in M3. The intragranular LZ content was especially high in M5 and in most granules of M4 cells. The immunogold reaction (IGR) for LZ was also performed in cells previously reacted for myeloperoxidase (MPO). In M2 the granules showed definite positive MPO reactivity and low LZ density (granulocytic pattern), whereas in M5 we found high granular LZ content and weak or almost negative MPO activity (monocytic pattern). In M4 we found 'granulocytic' and 'monocytic' type of granules in the same cell. The IGR for LZ performed in post-embedded M5 cells which were previously subjected to phagocytosis of latex particles, showed granules that had moved toward the phagosome, releasing LZ without degranulation. The above findings and those showing normal serum LZ in M3 despite their high cellular LZ content, definitely indicate that only leukaemic M4 and M5 cells secrete LZ into their environment, explaining the high serum LZ observed in those leukaemias.
引用
收藏
页码:357 / 363
页数:7
相关论文
共 25 条
[1]   ULTRASTRUCTURAL LOCALIZATION OF ENDOGENOUS MAMMARY-GLAND PEROXIDASE DURING LACTOGENESIS IN RAT - RESULTS AFTER TANNIC ACID-FORMALDEHYDE-GLUTARALDEHYDE FIXATION [J].
ANDERSON, WA ;
TRANTALIS, J ;
KANG, YH .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1975, 23 (04) :295-302
[2]   IMMUNOCYTOLOGICAL DEMONSTRATION OF LYSOZYME (MURAMIDASE) IN HUMAN LEUKAEMIC CELLS [J].
ASAMER, H ;
SCHMALZL, F ;
BRAUNSTEINER, H .
BRITISH JOURNAL OF HAEMATOLOGY, 1971, 20 (06) :571-+
[3]  
BENNET JM, 1985, ANN INTERN MED, V103, P625
[4]   PROPOSALS FOR CLASSIFICATION OF ACUTE LEUKEMIAS [J].
BENNETT, JM ;
CATOVSKY, D ;
DANIEL, MT ;
FLANDRIN, G ;
GALTON, DAG ;
GRALNICK, HR ;
SULTAN, C .
BRITISH JOURNAL OF HAEMATOLOGY, 1976, 33 (04) :451-&
[5]   LYSOZYME IN BONE MARROW AND PERIPHERAL BLOOD CELLS [J].
BRIGGS, RS ;
PERILLIE, PE ;
FINCH, SC .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1966, 14 (02) :167-&
[6]   SIGNIFICANCE OF LYSOZYME ESTIMATIONS IN ACUTE MYELOID AND CHRONIC MONOCYTIC LEUKAEMIA [J].
CATOVSKY, D ;
GALTON, DAG ;
GRIFFIN, C .
BRITISH JOURNAL OF HAEMATOLOGY, 1971, 21 (05) :565-&
[7]   LYSOZYME ACTIVITY AND NITROBLUE-TETRAZOLIUM REDUCTION IN LEUKEMIC CELLS [J].
CATOVSKY, D ;
GALTON, DAG .
JOURNAL OF CLINICAL PATHOLOGY, 1973, 26 (01) :60-69
[8]   SERUM LYSOZYME AND VITAMIN-B12 BINDING CAPACITY IN MYELOPROLIFERATIVE DISORDERS [J].
CATOVSKY, D ;
GALTON, DAG ;
GRIFFIN, C ;
HOFFBRAND, AV ;
SZUR, L .
BRITISH JOURNAL OF HAEMATOLOGY, 1971, 21 (06) :661-+
[9]   ULTRASTRUCTURAL-LOCALIZATION OF LYSOZYME IN HUMAN-NEUTROPHILS BY IMMUNOGOLD [J].
CRAMER, EM ;
BRETONGORIUS, J .
JOURNAL OF LEUKOCYTE BIOLOGY, 1987, 41 (03) :242-247
[10]   INVITRO SYNTHESIS AND SECRETION OF LYSOZYME BY MONONUCLEAR PHAGOCYTES [J].
GORDON, S ;
TODD, J ;
COHN, ZA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1974, 139 (05) :1228-1248